Skip to main content
. Author manuscript; available in PMC: 2014 Jul 8.
Published in final edited form as: Biotechniques. 2013 May;54(5):271–277. doi: 10.2144/000114027

Table 1.

Comparison of agonist EC50 values for different measures of platelet activation

Measure of activation Convulxin SFLLRN AYPGKF ADP U46619 PGE2
Cytosolic Ca2+ 5.3 nM 15.2 μM 112.4 μM 1.17 μM 1.19 μM 24.6 μM
PAC-1 1.6 nM 4.4 μM 267 μM 595 nM n/a 11.5 μM
anti-CD62P 2.4 nM 6.6 μM 223 μM 371 nM n/a 49.4 μM

Calculated EC50 values for platelet activation measured by binding of PAC-1 and anti-CD62P antibodies to ntegrin αIIbβ3 and P-selectin respectively and cytosolic Ca2+ values that were obtained previously. Platelet rich plasma was incubated with each of the five activating agonists, while PGE2 was coincubated with 15 μM SFLLRN. U46619 did not elicit significant antibody binding.